Trim MDLZ to 75% of target weight with $58.50 structural stop; reject Sell label as overshooting
The three-analyst debate converges on directional reduction but produces productive disagreement on execution that ultimately resolves toward the neutral analyst's calibration. The deterioration cluster is real and validated — price broke 50 SMA, 10 EMA, Bollinger middle, and VWAP in a single session; MACD negative cross confirmed; institutional distribution with 17M+ share sell days; buyback pause from ~$1.5B/quarter to $0 in Q1 2026; Q1 2026 margin reset to 8.9%. The structural floor at the 200 SMA ($58.79) has defended for 42+ sessions through this entire pullback, arguing against full exit. The 75% trim (25% reduction) splits the difference: meaningful enough to monetize the validated deterioration signal, light enough to preserve the defensive ballast the 200 SMA and 3.35% dividend justify. The $58.50 stop sits just below the 200 SMA, providing ~1.5 ATR of breathing room and aligning the invalidation trigger with the actual structural line in the sand. A stop at $62.00 equals entry price — undefined risk and a placeholder that triggers immediately on any gap down — is structurally incoherent and rejected. The trader's Sell label overshoots; the 75% trim execution is functionally Underweight. Going to zero forfeits re-entry optionality at the precise level where re-engagement becomes most attractive. The neutral analyst's 75% trim with $58.50 stop and defined re-entry rules is the cleanest synthesis that captures the bearish signal's alpha while preserving structural floor defense and re-engagement optionality.
| Position | Action |
|---|---|
| Weakness continues at $60 handle | Trim ~15% to lock in deterioration-cluster alpha |
| Rally into $61.95-$62.50 (50 SMA/Bollinger middle resistance zone) | Reserve ~10% trim capacity for optimal exit window |
| Any level — no new longs | Do NOT initiate new longs until confirmation |
| Confirmed close below $58.50 on volume ≥10M | Downgrade to Sell (full exit) |
| Confirmed close above $62.00 on volume ≥10M with MACD histogram positive | Upgrade to Hold (re-engagement) |
| Tactical warning zone | $60.67 lower Bollinger / 50 SMA zone |
| Re-engagement zone | $59.50-$60.50 on confirmed close >$62.00 with MACD positive |
MDLZ presents a high-conviction buy because the technical weakness (50 SMA break, lower Bollinger Band tag) is describing a temporary moment, not a structural regime change — with the critical 200 SMA at $58.79 still intact, the brand moat having proven its resilience through the worst cocoa shock in a generation, and upcoming catalysts from cocoa normalization and the Oreo 2027 relaunch, the downside is capped by a 6.35% total shareholder yield while the upside offers meaningful multiple expansion potential.
| Indicator | Value | Signal |
|---|---|---|
| close | 60.17 | bearish |
| volume | 9212644 | bearish |
| close_200_sma | 58.79 | bullish |
| close_50_sma | 62.00 | bearish |
| close_10_ema | 61.65 | bearish |
| macd | -0.28 | bearish |
| macds | -0.06 | bearish |
| macdh | -0.22 | bearish |
| rsi | 36.54 | bearish |
| boll | 62.16 | bearish |
| boll_ub | 63.99 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Re-engage; reclaim neutralizes momentum damage, preserves yield collection
The sell-off reflects sector rotation or positioning shakeout, not fundamental deterioration — there is no MDLZ-specific negative news.
↩ rebuts: “Bear acting as if fundamental deterioration is real despite admitting no MDLZ-specific bad news”
EV: Target 1: +3.3% ($62.00 reclaim of 50 SMA); Target 2: +6.5% ($64.00 BB upper band); oreo relaunch and cocoa normalization as catalysts over 3–6 months · concedes: Not a momentum buy — it's a value-at-a-defensive-name-with-a-yield-floor buy; Bear's recommendation to wait for confirmation is reasonable discipline for choppy markets
MDLZ is in a technical and fundamental regime change: the 50 SMA break on elevated volume signals institutional distribution, Q1 2026 earnings revealed a margin reset with net income down 40% sequentially, the 3.4% dividend yield is undercut by risk-free rates, and the bull's upside targets of +3.3-6.5% don't compensate for downside risk of -14.9% to the 52-week low.
· concedes: Grant the brand strength — Cadbury, Oreo, Toblerone are genuinely iconic franchises with pricing power; The dividend and FCF generation are real, even if coverage is tight; The Q1 2026 EPS of $1.20 could be a significant operational beat rather than a one-time gain, warranting further diligence
→ vs neutral: HOLD recommendation is 'hope dressed up in a suit' — anchoring on Q3 print instead of pricing information already in the tape; zero premium to wait with full downside exposure if earnings disappoint
→ vs conservative: Brand moat, Cadbury, Oreo, and 200 SMA 'cushion' do not justify full position at 50 SMA breakdown; moats are why you WANT to own lower in three months, not why you hold at current levels; 200 SMA is a magnet not a floor
| boll_lb | 60.33 | bearish |
| atr | 1.25 | neutral |
| vwma | 61.72 | bearish |
Support: 60.1 · 58.79 | Resistance: 62 · 62.16 · 63.99
MDLZ is in a short-term corrective phase within a still-intact long-term uptrend, with price breaking below the 50-day SMA at 62.00 and closing below the lower Bollinger Band at 60.33 on elevated volume (9.2M vs. baseline 6-8M). The MACD histogram is expanding negatively (-0.22) and RSI has declined to 36.54, confirming bearish momentum, though the 200-day SMA at 58.79 remains critical structural support. Trade stance is defensive/wait-and-see; a reclaim above 62.00-62.16 would invalidate the breakdown and trigger short-covering, while a close below 58.79 would signal a deeper regime shift.
Market Capitalization
$76.80 B
Share Price
~$60.14
52-Week Range
$51.20 – $66.65
50-Day Average
$61.98
200-Day Average
$59.35
PE Ratio (TTM)
22.04x
Forward PE
17.91x
PEG Ratio
0.90
Price / Book
2.89x
Dividend Yield
3.42%
Beta
0.40
TTM Revenue
$39.67 B
Gross Profit (TTM)
$12.36 B
Gross Margin
31.1%
EBITDA (TTM)
$6.08 B
EBITDA Margin
15.3%
Operating Margin
22.0%
Net Income (TTM)
$3.52 B
Profit Margin
8.9%
EPS (TTM)
$2.73
Forward EPS
$3.36
Forward EPS Growth
~23%
Total Assets
$71.12 B
Total Debt
$21.62 B
Net Debt
$19.50 B
Net Debt / EBITDA
~3.2x
Stockholders' Equity
$25.75 B
Goodwill
$24.23 B
Goodwill & Intangibles
$43.76 B
Net PPE
$11.29 B
Current Ratio
0.60
Working Capital
($10.76 B)
Invested Capital
$46.77 B
Cash & Equivalents
$1.52 B
Treasury Stock
$31.40 B
TTM Free Cash Flow
$2.25 B
FCF Yield
~2.93%
Total Shareholder Yield
~6.35%
Quarterly Capex
~$300M
Capital Expenditure (5Q total)
($1.59 B)
Quarterly Dividend
~$625M
Annualized Dividend
~$2.55/share
Share Repurchases (5Q total)
($2.39 B)
ROE
13.34%
ROA
4.12%
Book Value per Share
$20.80
Payout Ratio
~50%
Strengths
Concerns
Mondelez International is a defensive consumer staples play with a low beta of 0.40 and a portfolio of iconic global snack brands (Oreo, Cadbury, Toblerone) that provides pricing power and a ~6.35% total shareholder yield. The company is navigating elevated input costs (cocoa, sugar, dairy) that have compressed gross margins to 31.1% from historical 38-40% levels, but EBITDA margins are expanding sequentially and forward earnings growth of ~23% is expected (TTM EPS $2.73 to forward $3.36). The balance sheet shows investment-grade leverage (Net Debt/EBITDA ~3.2x) with $21.62B total debt against $71.12B in assets, though heavy intangibles of $43.76B (~62% of assets) create ongoing impairment risk, and share repurchases have recently stalled after $31.4B in historical buybacks.
Macro: No-cut Fed regime through 2026 (96% probability); US recession odds low and falling at 6%; risk appetite rotating into crypto/risk-on assets; capital flows away from defensive sectors.